BSS-4是一种迪奥斯基宁类比物,可以减少鼠类的卡拉基南诱导的脚炎症
Marisol Casimiro-Rosas1, Irving Parra1, Jesús Sandoval-Ramírez2
1Laboratorio de Neuroquímica, Facultad de Ciencias Químicas Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.
Steroids
|March 23, 2025
概括
在大鼠模型中,BSS-4是一种迪奥斯基宁模拟物,有效降低了炎症和关键炎症标志物,如瘤缩因子-α和互白素-1β. 这种化合物显示出作为一种强效和更安全的抗炎剂的前景.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 炎症是一种关键的免疫反应,但其过度活化可能是有害的.
- 目前的抗炎药物,如类固醇和NSAIDs具有限制和副作用.
- 需要新的,强效的,更安全的抗炎药物.
研究的目的:
- 为了评估BSS-4的抗炎疗效,它是一种迪奥斯基宁模拟剂.
- 在炎症模型中研究BSS-4的作用机制.
- 评估BSS-4对炎症性细胞因子标记物的影响.
主要方法:
- 在成年雄性Wistar大鼠中,卡拉基南诱导的脚胀模型.
- 通过腹腔内注射给予两剂BSS-4 (0.5和1毫克/公斤).
- 使用免疫组织化学和通过H&E染色对组织结构的评估来量化瘤亡因子-α (TNF-α) 和互白素-1β (IL-1β).
主要成果:
- 在0.5mg/kg的BSS-4显著减少了多达3小时的脚胀.
- 同时观察到TNF-α和IL-1β免疫抑制的显著降低.
- BSS-4治疗有助于保持正常的组织结构.
结论:
- BSS-4在原蛋白诱导的老鼠模型中显示出强大的抗炎作用.
- BSS-4有效地减少了关键的炎症媒介TNF-α和IL-1β.
- BSS-4显示出作为一种比现有的抗炎药物更安全的替代品的潜力.
关键词:
胡卜素是什么?胡卜素是什么?细胞因子 (cytokines) 是一种细胞因子.迪奥斯基因的存在湿疹和湿疹是一个问题.葡萄糖皮质类药物是什么在 H&E 染色方面在IL-1β的研究中,IL-1β被认为是IL-1β.炎症 炎症是一种炎症.没有NSAID可以治疗.这就是TNF-α.更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.6K
08:45Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein
Published on: September 29, 2021
5.2K
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
01:29Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83